首页> 外文OA文献 >Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)

【2h】

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)

机译：在6年期间，在单一机构治疗12例患有人源化的CCR4抗体（Mogamulizumab）治疗的临床特征，病理特征和治疗结果22例患有侵略性成人T细胞白血病淋巴瘤（2012-2018）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Noriaki Kawano; Noriaki Yoshida; Sayaka Kawano; Fumiko Arakawa; Hiroaki Miyoshi; Kyohei Yamada; Kazutaka Nakashima; Shuro Yoshida; Takuro Kuriyama; Taro Tochigi; Takashi Nakaike; Tomonori Shimokawa; Kiyoshi Yamashita; Kousuke Marutsuka; Koichi Mashiba; Ikuo Kikuchi; Koichi Ohshima;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018) [J] . Noriaki Kawano, Noriaki Yoshida, Sayaka Kawano, Internal medicine. . 2019,第15期

机译：在六年期间（2012-2018）在单一机构中用人源化CCR4抗体（Mogamulizumab）治疗22例侵袭性成人T细胞白血病-淋巴瘤的临床特征，病理特征和治疗结果
2. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014) [J] . Kawano Noriaki, Kuriyama Takuro, Sonoda Koh-Hei, Internal medicine. . 2016,第11期

机译：人源化CCR4抗体（莫加莫珠单抗）在三年内通过单一机构治疗的14例侵略性成人T细胞白血病-淋巴瘤的临床影响（2012-2014）
3. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014) [J] . Noriaki Kawano, Takuro Kuriyama, Koh-Hei Sonoda, Internal medicine. . 2016,第11期

机译：人性化CCR4抗体（莫加莫珠单抗）在三年内于单一机构治疗的14例侵略性成人T细胞白血病-淋巴瘤患者的临床影响（2012-2014）
4. Incidence and Clinical Features of Acute Lung Injury/ Adult Respiratory Distress Syndrome Complicating Acute Myocardial Infarction Patients Treated with Primary Angioplasty [C] . Garcia Gonzalez M.J., Juarez Prera R., Blanco Palacios G., International Congress on Coronary Artery Disease . 2009

机译：急性肺损伤/成人呼吸窘迫综合征复杂性急性心肌梗死患者的发病率和临床特征对初级血管成形术治疗的急性心肌梗死患者
5. Clinical Features Pathological Features and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018) [O] . Noriaki Kawano, Noriaki Yoshida, Sayaka Kawano, 2019

机译：在单一机构中用人源化CCR4抗体（Mogamulizumab）在6年期间（2012-2018）治疗22例侵袭性成人T细胞白血病-淋巴瘤的临床特征病理特征和治疗结果
6. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014) [O] . Noriaki Kawano, Takuro Kuriyama, Koh-Hei Sonoda, 2016

机译：人源化CCR4抗体（Mogamulizumab）在三年期间在单个机构治疗的14例侵略性成人T细胞白血病淋巴瘤患者中的临床影响（2012-2014）

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)

著录项

引文网络

相似文献

相关主题

期刊订阅